HCLTech named OpenAI Advanced Partner

HCLTech, a leading global technology company, announced that it has achieved OpenAI Advanced Partner status within the OpenAI Partner Network.

The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities and customer relationships while equipping them with resources, enablement and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact.

 

As an OpenAI Advanced Partner, HCLTech will continue working with OpenAI to help organizations build, deploy and scale AI-native Solutions responsibly, securely and at enterprise scale. HCLTech brings deep AI expertise across industries through its portfolio of sector-specific Industry AI Solutions, helping enterprises use GPT-5.6 and ChatGPT Work to accelerate adoption and drive measurable business value.

 

HCLTech’s AI-powered service transformation platform, AI Force, is also integrated with OpenAI models to help enterprises accelerate productivity, enhance service experiences and drive greater value from their AI investments.

 

As one of the Global Systems Integrators selected by OpenAI as a partner, HCLTech continues to collaborate closely with OpenAI to help enterprises accelerate adoption and maximize business value from their AI investments.

 

“We’re pleased to welcome HCLTech as an OpenAI Advanced Partner. The HCLTech team brings practical enterprise AI delivery experience across strategy, implementation and adoption,” said Colleen Kapase, Vice President of Strategic Global Partnerships and Ecosystems, OpenAI. “Through the OpenAI Partner Network, HCLTech can help more enterprises move from AI pilots to measurable business impact.”

 

“Being recognized as an OpenAI Advanced Partner reflects the strength of our strategic collaboration with OpenAI. Together, we are helping clients transition into new Agentic Operating model across values streams by building, deploying and scaling industrialized Enterprise AI operating systems and control towers to unlock measurable business value with AI,” said Raghu Kidambi, Corporate Vice President, AI Partnerships.

 

Building on its collaboration with OpenAI, HCLTech is expanding its OpenAI Agentic Transformation Studio to help enterprises build, govern and scale AI across business functions and industry workflows. The offering combines AI Governance, Agentic Engineering, AgentOps and optimization capabilities to accelerate AI adoption and deliver measurable business value.

 

Comments

Post a Comment

Popular posts from this blog

BPCL Dealer network launches “Fuelling the Festive Spirit” Campaign

Image
  Bharat Petroleum Corporation Limited (BPCL) dealer network has rolled out its festive season campaign, “Fuelling the Festive Spirit”, from 22nd September to 31st October 2025 across 3,000 Retail Outlets in Andhra Pradesh, Telangana, Karnataka, and Tamil Nadu.   Customers fuelling up with eligible transactions can win exciting prizes of 17 car and  83 Bikes through QR-based digital  slogan context participation. BPCL spokesperson said, “Festivals in India are a time of joy, giving, and togetherness. With ‘Fuelling the Festive Spirit,’ we are delighted to reward our customers and empower our frontline teams, making every visit to our retail outlets during this festive season truly memorable.”
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more

Gleneagles Hospital Successfully Treats Rare CNS (Brain) Lymphoma with Advanced CAR-T Cell Therapy

Image
Gleneagles Hospital Chennai, a part of Fortis Healthcare, has successfully treated a 49-year-old patient from Andhra Pradesh diagnosed with a rare and aggressive form of CNS(brain) lymphoma using advanced CAR-T cell therapy. Despite developing multiple serious treatment-related complications, the patient achieved complete remission and is doing well. The patient presented with complaints of persistent headache, giddiness, difficulty in walking, and weakness in his left arm and leg. Detailed investigations confirmed Primary Central Nervous System Lymphoma (PCNSL) , a rare type of lymphoma that affects the brain and is known to be difficult to treat. The patient initially received high-dose chemotherapy, the standard first-line treatment for this condition. However, the disease continued to progress despite four cycles of treatment. He subsequently underwent radiotherapy with chemotherapy, followed by oral targeted therapy as bridging treatment. As the lymphoma remained resistant to ...
Read more